Suppr超能文献

天疱疮样扁平苔藓,以黏膜为主:12 例患者系列及文献复习。

Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review.

机构信息

Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France.

Dermatology Department, Saint Pierre-Brugmann and Queen Fabiola Children's University Hospitals, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Front Immunol. 2024 Apr 15;15:1243566. doi: 10.3389/fimmu.2024.1243566. eCollection 2024.

Abstract

BACKGROUND

Lichen planus pemphigoides (LPP), an association between lichen planus and bullous pemphigoid lesions, is a rare subepithelial autoimmune bullous disease. Mucous membrane involvement has been reported previously; however, it has never been specifically studied.

METHODS

We report on 12 cases of LPP with predominant or exclusive mucous membrane involvement. The diagnosis of LPP was based on the presence of lichenoid infiltrates in histology and immune deposits in the basement membrane zone in direct immunofluorescence and/or immunoelectron microscopy. Our systematic review of the literature, performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, highlights the clinical and immunological characteristics of LPP, with or without mucous membrane involvement.

RESULTS

Corticosteroids are the most frequently used treatment, with better outcomes in LPP with skin involvement alone than in that with mucous membrane involvement. Our results suggest that immunomodulators represent an alternative first-line treatment for patients with predominant mucous membrane involvement.

摘要

背景

类天疱疮样扁平苔藓(lichen planus pemphigoides,LPP)是一种罕见的亚上皮自身免疫性大疱病,其特征为扁平苔藓和大疱性类天疱疮病变同时存在。黏膜受累此前已有报道,但从未对此进行专门研究。

方法

我们报告了 12 例以黏膜为主或仅黏膜受累的 LPP 患者。LPP 的诊断基于组织学中存在苔藓样浸润以及直接免疫荧光和/或免疫电镜下基底膜带免疫沉积物。我们根据系统评价和荟萃分析的首选报告项目进行了文献系统回顾,重点介绍了有或没有黏膜受累的 LPP 的临床和免疫学特征。

结果

皮质类固醇是最常用的治疗方法,仅皮肤受累的 LPP 比黏膜受累的 LPP 治疗效果更好。我们的结果表明,免疫调节剂代表了主要黏膜受累患者的一线替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c09/11057232/5cc9725bb1ce/fimmu-15-1243566-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验